aTYR PHARMA INC 10-Q filing
Filed 2026-05-15 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001339970-26-000033
- Form type
- 10-Q
- CIK
- 0001339970
- Primary document
- https://www.sec.gov/Archives/edgar/data/1339970/000133997026000033/atyr-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for aTYR PHARMA INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-11.4M | - | - |
| Net Income | $-10.8M | - | - |
| Eps Basic | -0.11 | - | - |
| Eps Diluted | -0.11 | - | - |
| Cash And Equivalents | $10.0M | - | - |
| Total Assets | $79.7M | - | - |
| Shareholders Equity | $57.9M | - | - |
| Operating Cash Flow | $-12.5M | - | - |
| Capital Expenditures | $138,000 | - | - |